Selected research
Industry Research
Drug Subcontractor Industry Research Report 2026
Market perspective
The global Drug Subcontractor market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Drug Subcontractor is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Drug Subcontractor is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Drug Subcontractor is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Drug Subcontractor include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Drug Subcontractor market in revenue (US$ million) and, where applicable, sales volume (units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Drug Subcontractor.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Subcontractor Market by Company
JVM
Takazono Corporation
TOSHO
JHNT
SANYO
Cretem
Allon Technology
Yuyama Manufacturing
Beijing Huakangxin Medical
Suzhou Huisiteng
Shanghai Qiyou Precision Mechanical and Electrical
Jiangsu Fowa Medical
Drug Subcontractor Segment by Type
Fully-automatic
Semi-automatic
Drug Subcontractor Segment by Application
Private Hospital
Public Hospital
Drug Subcontractor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Subcontractor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Subcontractor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Subcontractor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Drug Subcontractor manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Drug Subcontractor by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Drug Subcontractor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fully-automatic
- Semi-automatic
Applications
- Private Hospital
- Public Hospital
Companies covered
- JVM
- Takazono Corporation
- TOSHO
- JHNT
- SANYO
- Cretem
- Allon Technology
- Yuyama Manufacturing
- Beijing Huakangxin Medical
- Suzhou Huisiteng
- Shanghai Qiyou Precision Mechanical and Electrical
- Jiangsu Fowa Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Drug Subcontractor by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Fully-automatic
- 2.2.3 Semi-automatic
- 2.3 Drug Subcontractor by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Private Hospital
- 2.3.3 Public Hospital
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Drug Subcontractor Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Drug Subcontractor Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Drug Subcontractor Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Drug Subcontractor Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Drug Subcontractor Production by Manufacturers (2021-2026)
- 3.2 Global Drug Subcontractor Production Value by Manufacturers (2021-2026)
- 3.3 Global Drug Subcontractor Average Price by Manufacturers (2021-2026)
- 3.4 Global Drug Subcontractor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Drug Subcontractor Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Drug Subcontractor Manufacturers, Product Type & Application
- 3.7 Global Drug Subcontractor Manufacturers Established Date
- 3.8 Global Drug Subcontractor Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 JVM
- 4.1.1 JVM Drug Subcontractor Company Information
- 4.1.2 JVM Drug Subcontractor Business Overview
- 4.1.3 JVM Drug Subcontractor Production, Value and Gross Margin (2021-2026)
- 4.1.4 JVM Product Portfolio
- 4.1.5 JVM Recent Developments
- 4.2 Takazono Corporation
- 4.2.1 Takazono Corporation Drug Subcontractor Company Information
- 4.2.2 Takazono Corporation Drug Subcontractor Business Overview
- 4.2.3 Takazono Corporation Drug Subcontractor Production, Value and Gross Margin (2021-2026)
- 4.2.4 Takazono Corporation Product Portfolio
- 4.2.5 Takazono Corporation Recent Developments
- 4.3 TOSHO
- 4.3.1 TOSHO Drug Subcontractor Company Information
- 4.3.2 TOSHO Drug Subcontractor Business Overview
- 4.3.3 TOSHO Drug Subcontractor Production, Value and Gross Margin (2021-2026)
- 4.3.4 TOSHO Product Portfolio
- 4.3.5 TOSHO Recent Developments
- 4.4 JHNT
- 4.4.1 JHNT Drug Subcontractor Company Information
- 4.4.2 JHNT Drug Subcontractor Business Overview
- 4.4.3 JHNT Drug Subcontractor Production, Value and Gross Margin (2021-2026)
- 4.4.4 JHNT Product Portfolio
- 4.4.5 JHNT Recent Developments
- 4.5 SANYO
- 4.5.1 SANYO Drug Subcontractor Company Information
- 4.5.2 SANYO Drug Subcontractor Business Overview
- 4.5.3 SANYO Drug Subcontractor Production, Value and Gross Margin (2021-2026)
- 4.5.4 SANYO Product Portfolio
- 4.5.5 SANYO Recent Developments
- 4.6 Cretem
- 4.6.1 Cretem Drug Subcontractor Company Information
- 4.6.2 Cretem Drug Subcontractor Business Overview
- 4.6.3 Cretem Drug Subcontractor Production, Value and Gross Margin (2021-2026)
- 4.6.4 Cretem Product Portfolio
- 4.6.5 Cretem Recent Developments
- 4.7 Allon Technology
- 4.7.1 Allon Technology Drug Subcontractor Company Information
- 4.7.2 Allon Technology Drug Subcontractor Business Overview
- 4.7.3 Allon Technology Drug Subcontractor Production, Value and Gross Margin (2021-2026)
- 4.7.4 Allon Technology Product Portfolio
- 4.7.5 Allon Technology Recent Developments
- 4.8 Yuyama Manufacturing
- 4.8.1 Yuyama Manufacturing Drug Subcontractor Company Information
- 4.8.2 Yuyama Manufacturing Drug Subcontractor Business Overview
- 4.8.3 Yuyama Manufacturing Drug Subcontractor Production, Value and Gross Margin (2021-2026)
- 4.8.4 Yuyama Manufacturing Product Portfolio
- 4.8.5 Yuyama Manufacturing Recent Developments
- 4.9 Beijing Huakangxin Medical
- 4.9.1 Beijing Huakangxin Medical Drug Subcontractor Company Information
- 4.9.2 Beijing Huakangxin Medical Drug Subcontractor Business Overview
- 4.9.3 Beijing Huakangxin Medical Drug Subcontractor Production, Value and Gross Margin (2021-2026)
- 4.9.4 Beijing Huakangxin Medical Product Portfolio
- 4.9.5 Beijing Huakangxin Medical Recent Developments
- 4.10 Suzhou Huisiteng
- 4.10.1 Suzhou Huisiteng Drug Subcontractor Company Information
- 4.10.2 Suzhou Huisiteng Drug Subcontractor Business Overview
- 4.10.3 Suzhou Huisiteng Drug Subcontractor Production, Value and Gross Margin (2021-2026)
- 4.10.4 Suzhou Huisiteng Product Portfolio
- 4.10.5 Suzhou Huisiteng Recent Developments
- 4.11 Shanghai Qiyou Precision Mechanical and Electrical
- 4.11.1 Shanghai Qiyou Precision Mechanical and Electrical Drug Subcontractor Company Information
- 4.11.2 Shanghai Qiyou Precision Mechanical and Electrical Drug Subcontractor Business Overview
- 4.11.3 Shanghai Qiyou Precision Mechanical and Electrical Drug Subcontractor Production, Value and Gross Margin (2021-2026)
- 4.11.4 Shanghai Qiyou Precision Mechanical and Electrical Product Portfolio
- 4.11.5 Shanghai Qiyou Precision Mechanical and Electrical Recent Developments
- 4.12 Jiangsu Fowa Medical
- 4.12.1 Jiangsu Fowa Medical Drug Subcontractor Company Information
- 4.12.2 Jiangsu Fowa Medical Drug Subcontractor Business Overview
- 4.12.3 Jiangsu Fowa Medical Drug Subcontractor Production, Value and Gross Margin (2021-2026)
- 4.12.4 Jiangsu Fowa Medical Product Portfolio
- 4.12.5 Jiangsu Fowa Medical Recent Developments
5 Global Drug Subcontractor Production by Region
- 5.1 Global Drug Subcontractor Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Drug Subcontractor Production by Region: 2021-2032
- 5.2.1 Global Drug Subcontractor Production by Region: 2021-2026
- 5.2.2 Global Drug Subcontractor Production Forecast by Region (2027-2032)
- 5.3 Global Drug Subcontractor Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Drug Subcontractor Production Value by Region: 2021-2032
- 5.4.1 Global Drug Subcontractor Production Value by Region: 2021-2026
- 5.4.2 Global Drug Subcontractor Production Value Forecast by Region (2027-2032)
- 5.5 Global Drug Subcontractor Market Price Analysis by Region (2021-2026)
- 5.6 Global Drug Subcontractor Production and Value, YOY Growth
- 5.6.1 North America Drug Subcontractor Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Drug Subcontractor Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Drug Subcontractor Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Drug Subcontractor Production Value Estimates and Forecasts (2021-2032)
6 Global Drug Subcontractor Consumption by Region
- 6.1 Global Drug Subcontractor Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Drug Subcontractor Consumption by Region (2021-2032)
- 6.2.1 Global Drug Subcontractor Consumption by Region: 2021-2026
- 6.2.2 Global Drug Subcontractor Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Drug Subcontractor Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Drug Subcontractor Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Drug Subcontractor Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Drug Subcontractor Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Drug Subcontractor Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Drug Subcontractor Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Drug Subcontractor Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Drug Subcontractor Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Drug Subcontractor Production by Type (2021-2032)
- 7.1.1 Global Drug Subcontractor Production by Type (2021-2032) & (units)
- 7.1.2 Global Drug Subcontractor Production Market Share by Type (2021-2032)
- 7.2 Global Drug Subcontractor Production Value by Type (2021-2032)
- 7.2.1 Global Drug Subcontractor Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Drug Subcontractor Production Value Market Share by Type (2021-2032)
- 7.3 Global Drug Subcontractor Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Drug Subcontractor Production by Application (2021-2032)
- 8.1.1 Global Drug Subcontractor Production by Application (2021-2032) & (units)
- 8.1.2 Global Drug Subcontractor Production Market Share by Application (2021-2032)
- 8.2 Global Drug Subcontractor Production Value by Application (2021-2032)
- 8.2.1 Global Drug Subcontractor Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Drug Subcontractor Production Value Market Share by Application (2021-2032)
- 8.3 Global Drug Subcontractor Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Drug Subcontractor Value Chain Analysis
- 9.1.1 Drug Subcontractor Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Drug Subcontractor Production Mode & Process
- 9.2 Drug Subcontractor Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Drug Subcontractor Distributors
- 9.2.3 Drug Subcontractor Customers
10 Global Drug Subcontractor Analyzing Market Dynamics
- 10.1 Drug Subcontractor Industry Trends
- 10.2 Drug Subcontractor Industry Drivers
- 10.3 Drug Subcontractor Industry Opportunities and Challenges
- 10.4 Drug Subcontractor Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst